Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Sodium pyrrolidone carboxylate
Alliance Pharma (Ireland) Limited
D02AX
Sodium pyrrolidone carboxylate
2.5 percent weight/weight
Cream
Other emollients and protectives
Not marketed
2006-08-11
Sodium pyrrolidone carboxylate 2.5% w/w Cream PIL ROI 009 LOGO SODIUM PYRROLIDONE CARBOXYLATE 2.5% W/W CREAM INFORMATION FOR PATIENTS READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to use Sodium pyrrolidone carboxylate 2.5% w/w Cream carefully to get the best results from it. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • You must contact a doctor if your symptoms worsen or do not improve. • If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. The information in this leaflet has been divided into the following sections: 1. SODIUM PYRROLIDONE CARBOXYLATE 2.5% W/W CREAM IS AND WHAT IT IS USED FOR 2. CHECK BEFORE YOU USE SODIUM PYRROLIDONE CARBOXYLATE 2.5% W/W CREAM 3. HOW TO USE SODIUM PYRROLIDONE CARBOXYLATE 2.5% W/W CREAM 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE SODIUM PYRROLIDONE CARBOXYLATE 2.5% W/W CREAM 6. FURTHER INFORMATION 1. WHAT SODIUM PYRROLIDONE CARBOXYLATE 2.5% W/W CREAM IS AND WHAT IT IS USED FOR Sodium pyrrolidone carboxylate 2.5% w/w Cream is a soft, white cream which moisturises the skin. Sodium pyrrolidone carboxylate 2.5% w/w Cream contains a naturally occurring moisturising agent as well as oils, which prevent moisture loss from the skin. This helps to relieve itch, lubricate and soften the skin. Sodium pyrrolidone carboxylate 2.5% w/w Creamis used to treat any condition in which dry skin is a feature such as eczema, ichthyosis (hereditary dry skin) and senile pruritus (itching that may occur in old age). 2. CHECK BEFORE YOU USE SODIUM PYRROLIDONE CARBOXYLATE 2.5% W/W CREAM DO NOT USE SODIUM PYRROLIDONE CARBOXYLATE 2.5% W/W CREAM: • if you are allergic (hypersensitive) to sodium pyrrolidone carboxylate or any of the ingredients of Sodium pyrrolidone carboxylate 2.5% w/w Cream (see section 6 Further information). Sodium p Read the complete document
Health Products Regulatory Authority 26 March 2019 CRN008KJP Page 1 of 3 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sodium pyrrolidone carboxylate 2.5 % w/w Cream 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium Pyrrolidone Carboxylate 2.50 % w/w. Excipients: Contains cetostearyl alcohol 4%w/w. Contains hydroxybenzoates (parabens) approximately 1%w/w: methyl (E218), ethyl (E214), propyl (E216) and butyl parahydroxybenzoates. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Cream Soft, white oil-in-water cream. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As a lubricant and hydrating agent in the management of dry skin conditions such as certain types of eczema, ichthyosis and senile pruritus. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of administration For topical use only. ADULTS, CHILDREN AND THE ELDERLY: Apply liberally to the affected area and massage well into the skin. Sodium pyrrolidone carboxylate 2.5 % w/w Cream may be used as often as required. Sodium pyrrolidone carboxylate 2.5 % w/w Cream is especially beneficial when used immediately after washing or bathing, when the resultant warmth of the skin enhances absorption. 4.3 CONTRAINDICATIONS There are no contraindications except true hypersensitivity to any of the ingredients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE If there is aggravation of the condition consult the doctor. The formulation is not designed for use as a diluent. Health Products Regulatory Authority 26 March 2019 CRN008KJP Page 2 of 3 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTIONS None known. 4.6 FERTILITY, PREGNANCY AND LACTATION Sodium pyrrolidone carboxylate 2.5 % w/w Cream is not contra-indicated in pregnancy or lactation. 4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES Not applicable. 4.8 UNDESIRABLE EFFECTS Rarely a non serious allergic type reaction may be experienced, e.g. rash. REPORTING OF SUSPECTED ADVERSE REACTIONS Reporting suspected adverse reactions after authorisation of the medi Read the complete document